Genetically predicted circulating interleukin-18 levels are associated with risk of systemic lupus erythematosus and type 1 diabetes

Abstract

Objective

Interleukin-18 (IL-18) is a proinflammatory cytokine. This study aims to determine whether there is a causal relationship between circulating IL-18 concentrations and the risk of inflammatory and autoimmune diseases.

Methods

We collected significant single nucleotide polymorphisms (SNPs) associated with circulating IL-18 levels (p < 5 × 10⁻⁸) as instrumental variables (IVs) from a genome-wide association study (GWAS) involving 21,758 individuals of European descent. We mainly employed the inverse-variance weighed (IVW) method of two-sample Mendelian randomization (TSMR) analysis to estimate the causality of circulating IL-18 levels on inflammatory and autoimmune diseases.

Results

The IVW method results showed evidence of a causal relationship between IL-18 and the risk of systemic lupus erythematosus (SLE) (OR = 1.32; 95% CI 1.15, 1.50; p < .001) and type 1 diabetes (T1D) (OR = 1.22; 95% CI 1.06, 1.42; p = .007) in individuals of European ancestry. No significant heterogeneity or horizontal pleiotropy for SLE and T1D was detected. The sensitivity analysis, which involved removing confounding SNP, produced similar results for SLE and T1D. The results of sensitivity analysis using leave-one-out method indicated no single SNP significantly influenced the analysis results. However, we did not find any significant findings for multiple sclerosis, psoriasis, asthma, and osteoarthritis.

Conclusions

Our analyses suggest that circulating IL-18 is significantly related to SLE and T1D and may serve as a potential target for the treatment of these diseases.

Keywords

Systemic lupus erythematosus type 1 diabetes interleukin-18 mendelian randomization

Get full access to this article

View all access options for this article.

References

Sedimbi

Hägglöf

Karlsson

. IL-18 in inflammatory and autoimmune disease. Cell Mol Life Sci 2013; 70: 4795–4808.

Kaplanski

. Interleukin-18: biological properties and role in disease pathogenesis. Immunol Rev 2018; 281: 138–153.

Siegmund

Fantuzzi

Rieder

, et al. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am J Physiol Regul Integr Comp Physiol 2001; 281: 64–73.

Wei

Leung

Arthur

, et al. Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18. J Immunol 2001; 166: 517–521.

Wang

, et al. Telomere length and development of systemic lupus erythematosus: a mendelian randomization study. Arthritis Rheumatol 2022; 74: 1984–1990.

Liu

Pei

, et al. Mendelian randomization study for the roles of IL-18 and IL-1 receptor antagonist in the development of inflammatory bowel disease. Int Immunopharm 2022; 110: 109020.

Yuan

Lin

, et al. Interleukins and rheumatoid arthritis: bi-directional Mendelian randomization investigation. Semin Arthritis Rheum 2022; 53: 151958.

Folkersen

Gustafsson

Wang

, et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat Metab 2020; 2: 1135–1148.

Hemani

Zheng

Elsworth

, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife 2018; 7: e34408.

10.

Yuan

Carter

Mason

, et al. Genetic liability to rheumatoid arthritis in relation to coronary artery disease and stroke risk. Arthritis Rheumatol 2022; 74: 1638–1647.

11.

Lin

Brown

Machiela

. LDtrait: an online tool for identifying published phenotype associations in linkage disequilibrium. Cancer Res 2020; 80: 3443–3446.

12.

Xiang

Feng

Wang

, et al. Correlation between circulating interleukin-18 level and systemic lupus erythematosus: a meta-analysis. Sci Rep 2021; 11: 4707.

13.

Mende

Vincent

Kandane-Rathnayake

, et al. Analysis of serum interleukin (IL)-1β and IL-18 in systemic lupus erythematosus. Front Immunol 2018; 9: 1250.

14.

Nicoletti

Conget

Di Marco

, et al. Serum levels of the interferon gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes. Diabetologia 2001; 44: 309–311.

15.

Zeller

Haase

Müller

, et al. Molecular characterization of the NLRC4 expression in relation to interleukin-18 levels. Circ Cardiovasc Genet 2015; 8: 717–726.

16.

Neumann

Del Giudice

Ciaramella

, et al. Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain. J Immunol 2001; 166: 3757–3762.

17.

Bossù

Neumann

Del Giudice

, et al. IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. Proc Natl Acad Sci U S A 2003; 100: 14181–14186.

18.

Marleau

Sarvetnick

. IL-18 is required for self-reactive T cell expansion in NOD mice. J Autoimmun 2011; 36: 263–277.

19.

Zaccone

Phillips

Conget

, et al. IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse. Clin Immunol 2005; 115: 74–79.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.10 MB